Literature DB >> 9175848

Comparison of ribosome-inactivating proteins in the induction of apoptosis.

J M Williams1, N Lea, J M Lord, L M Roberts, D V Milford, C M Taylor.   

Abstract

The aim of this study was to evaluate the ability of verocytotoxin-1 (VT1), VT1 B chain alone, ricin and a hybrid toxin (RASTA2) consisting of ricin A chain linked to VT1 B chain to inhibit protein synthesis and to induce apoptosis. The lethal effects of the toxins were compared using vero cells (originating from green African monkey kidney tissue). As previously described cell death occurred through apoptosis which was quantified using the diphenylamine assay. DNA fragmentation was seen with VT1 at 10 pg/ml but there was no effect with B chain alone. Fragmentation with ricin was seen at 10 ng/ml and with RASTA2 at 1 ng/ml. Protein synthesis inhibition was measured by [(35)S]methionine incorporation. VT1 had an IC50 of 0.0024 ng/ml, B chain alone was ineffective at inhibiting protein synthesis. Ricin had an IC50 of 0.39 ng/ml and RASTA2 of 1.7 ng/ml. In vero cells the B chain of these toxins does not participate in cell killing.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9175848     DOI: 10.1016/s0378-4274(97)03879-4

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  13 in total

1.  Two distinct cytotoxic activities of subtilase cytotoxin produced by shiga-toxigenic Escherichia coli.

Authors:  Naoko Morinaga; Kinnosuke Yahiro; Gen Matsuura; Masaharu Watanabe; Fumio Nomura; Joel Moss; Masatoshi Noda
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

2.  Study on induction of apoptosis on HeLa and Vero cells by recombinant shiga toxin and its subunits.

Authors:  Saeid Bouzari; Mana Oloomi; Kayhan Azadmanesh
Journal:  Cytotechnology       Date:  2009-08-09       Impact factor: 2.058

Review 3.  Shiga toxins--from cell biology to biomedical applications.

Authors:  Ludger Johannes; Winfried Römer
Journal:  Nat Rev Microbiol       Date:  2009-12-21       Impact factor: 60.633

4.  Cloned Shiga toxin 2 B subunit induces apoptosis in Ramos Burkitt's lymphoma B cells.

Authors:  Paola Marcato; George Mulvey; Glen D Armstrong
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

5.  mkp-1 encoding mitogen-activated protein kinase phosphatase 1, a verotoxin 1 responsive gene, detected by differential display reverse transcription-PCR in Caco-2 cells.

Authors:  S Kojima; I Yanagihara; G Kono; T Sugahara; H Nasu; M Kijima; A Hattori; T Kodama; K I Nagayama; T Honda
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

6.  Inhibition of water absorption in human proximal tubular epithelial cells in response to Shiga toxin-2.

Authors:  Claudia Silberstein; Virginia Pistone Creydt; Elizabeth Gerhardt; Pablo Núñez; Cristina Ibarra
Journal:  Pediatr Nephrol       Date:  2008-07-08       Impact factor: 3.714

Review 7.  Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies.

Authors:  Robert J Kreitman
Journal:  BioDrugs       Date:  2009       Impact factor: 5.807

8.  Expression of Sambucus nigra agglutinin (SNA-I') from elderberry bark in transgenic tobacco plants results in enhanced resistance to different insect species.

Authors:  Shahnaz Shahidi-Noghabi; Els J M Van Damme; Guy Smagghe
Journal:  Transgenic Res       Date:  2008-08-22       Impact factor: 2.788

9.  Development of DNA vaccines against hemolytic-uremic syndrome in a murine model.

Authors:  Alejandra V E Capozzo; Virginia Pistone Creydt; Graciela Dran; Gabriela Fernández; Sonia Gómez; Leticia V Bentancor; Carolina Rubel; Cristina Ibarra; Martín Isturiz; Marina S Palermo
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

10.  Regulation of Caspase-3 and Bcl-2 Expression in Dalton's Lymphoma Ascites Cells by Abrin.

Authors:  V Ramnath; P S Rekha; G Kuttan; R Kuttan
Journal:  Evid Based Complement Alternat Med       Date:  2007-11-01       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.